Ignite Creation Date:
2025-12-25 @ 4:23 AM
Ignite Modification Date:
2026-03-05 @ 12:18 AM
Study NCT ID:
NCT01317420
Status:
COMPLETED
Last Update Posted:
2025-07-11
First Post:
2011-03-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Trial to Determine MTD of BI 836845 Administered Intravenously Once Every Three Weeks in Patients With Advanced Solid Tumours and Later a Weekly Dosing Schedule in Selected Tumour Types
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-04-13
Start Date Type:
ACTUAL
Primary Completion Date:
2016-02-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-02-15
Completion Date Type:
ACTUAL
First Submit Date:
2011-03-15
First Submit QC Date:
None
Study First Post Date:
2011-03-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2025-05-14
Results First Submit QC Date:
None
Results First Post Date:
2025-07-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-23
Last Update Post Date:
2025-07-11
Last Update Post Date Type:
ACTUAL